###begin article-title 0
###xml 25 33 25 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5,</italic>
###xml 57 64 <span type="species:ncbi:9606">Patient</span>
DNA Sequence Analysis of SLC26A5, Encoding Prestin, in a Patient-Control Cohort: Identification of Fourteen Novel DNA Sequence Variations
###end article-title 0
###begin p 1
Conceived and designed the experiments: JSM HYT FAP RLA. Performed the experiments: JSM HYT. Analyzed the data: JSM HYT FAP RLA. Wrote the paper: JSM HYT FAP RLA.
###end p 1
###begin p 2
Current address: Department of Otolaryngology, University of Colorado Denver Health Sciences Center, Aurora, Colorado, United States of America
###end p 2
###begin title 3
Background
###end title 3
###begin p 4
###xml 29 36 29 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
###xml 304 311 304 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
###xml 236 240 <span type="species:ncbi:10090">mice</span>
###xml 261 267 <span type="species:ncbi:9606">humans</span>
###xml 402 407 <span type="species:ncbi:9606">human</span>
###xml 479 485 <span type="species:ncbi:9606">humans</span>
Prestin, encoded by the gene SLC26A5, is a transmembrane protein of the cochlear outer hair cell (OHC). Prestin is required for the somatic electromotile activity of OHCs, which is absent in OHCs and causes severe hearing impairment in mice lacking prestin. In humans, the role of sequence variations in SLC26A5 in hearing loss is less clear. Although prestin is expected to be required for functional human OHCs, the clinical significance of reported putative mutant alleles in humans is uncertain.
###end p 4
###begin title 5
Methodology/Principal Findings
###end title 5
###begin p 6
###xml 31 38 31 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
###xml 210 217 210 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
###xml 352 356 352 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GJB2</italic>
###xml 429 436 429 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
###xml 531 538 531 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
###xml 888 895 888 895 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
###xml 1051 1060 1051 1060 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In silico</italic>
###xml 143 150 <span type="species:ncbi:9606">patient</span>
###xml 264 272 <span type="species:ncbi:9606">Patients</span>
###xml 635 643 <span type="species:ncbi:9606">patients</span>
###xml 782 790 <span type="species:ncbi:9606">patients</span>
###xml 963 971 <span type="species:ncbi:9606">patients</span>
###xml 1234 1242 <span type="species:ncbi:9606">patients</span>
###xml 1407 1415 <span type="species:ncbi:9606">patients</span>
###xml 1465 1472 <span type="species:ncbi:9606">patient</span>
To explore the hypothesis that SLC26A5 may act as a modifier gene, affecting the severity of hearing loss caused by an independent etiology, a patient-control cohort was screened for DNA sequence variations in SLC26A5 using sequencing and allele specific methods. Patients in this study carried known pathogenic or controversial sequence variations in GJB2, encoding Connexin 26, or confirmed or suspected sequence variations in SLC26A5; controls included four ethnic populations. Twenty-three different DNA sequence variations in SLC26A5, 14 of which are novel, were observed: 4 novel sequence variations were found exclusively among patients; 7 novel sequence variations were found exclusively among controls; and, 12 sequence variations, 3 of which are novel, were found in both patients and controls. Twenty-one of the 23 DNA sequence variations were located in non-coding regions of SLC26A5. Two coding sequence variations, both novel, were observed only in patients and predict a silent change, p.S434S, and an amino acid substitution, p.I663V. In silico analysis of the p.I663V amino acid variation suggested this variant might be benign. Using Fisher's exact test, no statistically significant difference was observed between patients and controls in the frequency of the identified DNA sequence variations. Haplotype analysis using HaploView 4.0 software revealed the same predominant haplotype in patients and controls and derived haplotype blocks in the patient-control cohort similar to those generated from the International HapMap Project.
###end p 6
###begin title 7
Conclusions/Significance
###end title 7
###begin p 8
###xml 54 61 54 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
###xml 89 93 89 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GJB2</italic>
###xml 249 256 249 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
Although these data fail to support a hypothesis that SLC26A5 acts as a modifier gene of GJB2-related hearing loss, the sample size is small and investigation of a larger population might be more informative. The 14 novel DNA sequence variations in SLC26A5 reported here will serve as useful research tools for future studies of prestin.
###end p 8
###begin title 9
Introduction
###end title 9
###begin p 10
###xml 122 125 122 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005762-Conner1">[1]</xref>
###xml 127 130 127 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005762-Dallos1">[2]</xref>
###xml 945 948 945 948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005762-Dallos2">[3]</xref>
###xml 950 953 950 953 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005762-Zheng1">[4]</xref>
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human ear is capable of perceiving sounds from 20-20,000 Hz and can distinguish a difference of as little as 0.2-0.5% [1], [2]. Such sensitivity and precision, seen also among other mammals, derives from a complex interaction of cochlear hair cells and the tectorial membrane (TM) within the organ of Corti. Stereocilia, which sit atop the outer hair cells (OHCs), embed within the TM and are deflected with the passage of sound pressure waves, triggering mechanotransducer ion channels to open and close, allowing the cell to depolarize and hyperpolarize, respectively. These changes in OHC membrane potential are converted into mechanical forces, causing the cell to rapidly lengthen and shorten, and in turn, move the basilar membrane, to result in a hundred-fold amplification of sound and a vastly improved ability to discriminate frequencies. An essential protein responsible for the electromechanical conversion in the OHC is prestin [3], [4].
###end p 10
###begin p 11
###xml 4 11 4 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
###xml 184 187 184 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005762-Zheng1">[4]</xref>
###xml 188 191 188 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005762-Schaechinger1">[6]</xref>
###xml 404 407 404 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005762-Mount1">[7]</xref>
###xml 466 473 466 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
###xml 532 535 532 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005762-Zheng2">[8]</xref>
###xml 343 348 <span type="species:ncbi:10090">mouse</span>
###xml 353 358 <span type="species:ncbi:9606">human</span>
The SLC26A5 gene encodes prestin. Most genes of the SLC26 family encode anion transporters, however, mammalian prestin has only been demonstrated to be an incomplete anion transporter [4]-[6]. Further, prestin is more highly conserved among mammalian species than any other protein in its family: demonstrating 95% amino acid identity between mouse and human, compared to an average of 86% for the group [7]. Prestin also appears to have a role beyond the OHC since SLC26A5 transcripts are found in heart, spleen, brain, and testis [8].
###end p 11
###begin p 12
###xml 65 68 65 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005762-Liberman1">[9]</xref>
###xml 194 198 194 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005762-Deak1">[10]</xref>
###xml 199 203 199 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005762-Rajagopalan1">[13]</xref>
###xml 285 292 285 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
###xml 339 343 339 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005762-VanCamp1">[14]</xref>
###xml 28 32 <span type="species:ncbi:10090">mice</span>
###xml 320 325 <span type="species:ncbi:9606">human</span>
Homozygous prestin knockout mice display a 40-60 dB hearing loss [9]. Mutational analyses by several groups have identified many residues that are essential for and/or modulate prestin function [10]-[13]. However, linkage studies of hearing impaired families have failed so far to map SLC26A5 as a locus associated with human hearing loss [14].
###end p 12
###begin p 13
###xml 73 80 73 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
###xml 340 344 340 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005762-Liu1">[15]</xref>
###xml 501 505 501 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005762-Tang1">[16]</xref>
###xml 737 741 737 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005762-Applied1">[17]</xref>
###xml 946 950 946 950 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005762-Toth1">[18]</xref>
###xml 84 90 <span type="species:ncbi:9606">humans</span>
###xml 836 843 <span type="species:ncbi:9606">patient</span>
Only three sequence variations presumed to affect the coding sequence of SLC26A5 in humans have been reported to date. In 2003, Liu et al. reported a DNA sequence variation, IVS2-2A>G, in a population that included two deaf probands homozygous for the variant. The IVS2-2A>G variant was predicted to disrupt the exon 3 splice acceptor site [15]. However, in 2005, we reported a carrier frequency among Caucasian controls of 4.1% for this variant, precluding its involvement in hereditary hearing loss [16]. In addition, the Celera database includes a missense variation, p.I67V, however, nothing is known about the hearing status of the individual carrying this variant, prohibiting audiometric assessment of its potential pathogenicity [17]. Recently, in 2007, Toth et al. reported a p.R150Q missense variation in one hearing impaired patient and his normal hearing father, suggesting the p.R150Q variant is not sufficient to cause hearing loss [18].
###end p 13
###begin p 14
###xml 115 119 115 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005762-Applied1">[17]</xref>
###xml 209 216 209 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
###xml 216 220 216 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005762-Database1">[19]</xref>
###xml 283 290 283 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
###xml 393 400 393 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
###xml 572 579 572 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
###xml 647 654 647 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
###xml 203 208 <span type="species:ncbi:9606">human</span>
###xml 277 282 <span type="species:ncbi:9606">human</span>
###xml 313 320 <span type="species:ncbi:9606">patient</span>
At the time this study was undertaken, the p.I67V variant was the only reported amino acid substitution in prestin [17] and only 447 non-coding SNPs were reported in the 49.24 kilobase genomic region of human SLC26A5[19]. Due to the paucity of known sequence variations in the human SLC26A5 gene, evaluation of a patient-control cohort was undertaken to seek additional sequence variations in SLC26A5 and explore the hypothesis that variations in prestin might modify the degree of hearing loss caused by an independent etiology. Fourteen novel DNA sequence variations in SLC26A5 were identified, however, no evidence supporting a hypothesis that SLC26A5 might act as a modifier gene was obtained.
###end p 14
###begin title 15
Results
###end title 15
###begin title 16
Analysis of the SLC26A5 DNA sequence
###end title 16
###begin p 17
###xml 189 196 189 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
###xml 370 377 370 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005762-t001">Table 1</xref>
###xml 497 504 497 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
###xml 521 528 521 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
###xml 98 105 <span type="species:ncbi:9606">patient</span>
Genomic DNA isolated from peripheral blood lymphocytes or cultured lymphoblastoid cell lines of a patient-control cohort was evaluated for 11 previously reported DNA sequence variations in SLC26A5 using DNA sequencing and allele specific methods. In the course of evaluating these 11 previously known sequence variations, 14 novel DNA sequence variations were observed. Table 1 shows the genomic DNA position, nucleotide sequence variation, polymorphism identification number, and location in the SLC26A5 gene for all 25 SLC26A5 sequence variations evaluated.
###end p 17
###begin title 18
###xml 27 34 27 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
DNA sequence variations in SLC26A5.
###end title 18
###begin p 19
###xml 130 134 130 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005762-Database1">[19]</xref>
###xml 165 172 165 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
###xml 222 226 222 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005762-Applied1">[17]</xref>
Entrez database () reference sequence genomic DNA positions and nucleotide (splice site/protein) variations, dbSNP SNP ID numbers [19], and genetic locations within SLC26A5 are shown. *formerly hCG1811409, Celera database [17]. IVS = intervening sequence (intron). Novel variants are shown in bold type.
###end p 19
###begin title 20
###xml 47 55 <span type="species:ncbi:9606">patients</span>
SLC26A5 DNA sequence variations observed among patients
###end title 20
###begin p 21
###xml 88 95 88 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
###xml 489 496 489 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
###xml 628 635 628 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005762-t001">Table 1</xref>
###xml 637 644 637 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005762-t002">Table 2</xref>
###xml 121 129 <span type="species:ncbi:9606">patients</span>
###xml 320 328 <span type="species:ncbi:9606">patients</span>
Sixteen different DNA sequence variations, 7 of which are novel, were identified in the SLC26A5 gene in hearing impaired patients. Sequence variations included 15 single nucleotide substitutions, 6 of which are novel, and 1 novel small (tri-nucleotide) deletion. Fourteen of the DNA sequence variations identified among patients, 13 single nucleotide substitutions and the 1 small deletion, were found in introns, while 2 single nucleotide substitutions were found in the coding region of SLC26A5 including g.56167A>G which predicts a synonymous change p.S434S and g.69743A>G which predicts the amino acid substitution p.I663V (Table 1, Table 2).
###end p 21
###begin title 22
###xml 56 63 56 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
Reference sequence allele frequencies for variations in SLC26A5.
###end title 22
###begin p 23
###xml 136 137 136 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 173 181 <span type="species:ncbi:9606">patients</span>
Allele frequencies of reference sequence nucleotides are provided for each DNA sequence variant. n = the number of chromosomes studied. P values are calculated by comparing patients to the combined control group. Novel variants are shown in bold type.
###end p 23
###begin p 24
###xml 59 66 59 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
###xml 94 101 94 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
###xml 4 11 <span type="species:ncbi:9606">patient</span>
The patient carrying the heterozygous p.S434S variation in SLC26A5 is also homozygous for the SLC26A5 variants g.33167T>C (dbSNP rs7779997), g.56471G>A (dbSNP rs4285410), g.67439T>C (dbSNP rs12705120) and g.69036T>C (dbSNP rs10273883) (data not shown).
###end p 24
###begin p 25
###xml 59 66 59 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
###xml 96 103 96 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
###xml 241 248 241 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
###xml 4 11 <span type="species:ncbi:9606">patient</span>
The patient carrying the heterozygous p.I663V variation in SLC26A5 is also heterozygous for the SLC26A5 variants g.33167T>C (dbSNP rs7779997), g.57137T>C (dbSNP rs62482415), and g.69917_69919delTCT (dbSNP rs66928926), and homozygous for the SLC26A5 variants g.56471G>A (dbSNP rs4285410), g.67439T>C (dbSNP rs12705120) and g.69036T>C (dbSNP rs10273883) (data not shown).
###end p 25
###begin p 26
###xml 91 98 91 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
###xml 42 50 <span type="species:ncbi:9606">patients</span>
DNA sequence variations were not found in patients in the coding or near coding regions of SLC26A5 exons 4, 7, 8, 9, 17, 20, or 21.
###end p 26
###begin title 27
SLC26A5 DNA sequence variations observed among controls
###end title 27
###begin p 28
###xml 90 97 90 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
###xml 369 376 369 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005762-t001">Table 1</xref>
###xml 378 385 378 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005762-t002">Table 2</xref>
###xml 471 478 471 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
###xml 518 526 <span type="species:ncbi:9606">patients</span>
Nineteen different DNA sequence variations, 10 of which are novel, were identified in the SLC26A5 gene in controls. Sequence variations included 17 single nucleotide substitutions, 8 of which are novel, and 2 novel small deletions (1 tri-nucleotide deletion and 1 penta-nucleotide deletion). All DNA sequence variations identified among controls were found in introns (Table 1, Table 2). Due to the lack of DNA sequence variations in the coding or near coding regions of SLC26A5 exons 4, 7, 8, 9, 17, 20, and 21 among patients, these exons were not analyzed in controls.
###end p 28
###begin title 29
Analysis of heterozygosity of sequence variations
###end title 29
###begin p 30
###xml 15 18 15 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(H)</italic>
###xml 106 113 106 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005762-t003">Table 3</xref>
###xml 210 217 210 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
###xml 248 255 248 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005762-t002">Table 2</xref>
###xml 257 264 257 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005762-t003">Table 3</xref>
###xml 349 357 349 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5.</italic>
###xml 72 80 <span type="species:ncbi:9606">patients</span>
Heterozygosity (H) for each of the DNA sequence variations evaluated in patients and controls is shown in Table 3. Allelic variation was observed for all but 2 of the 11 previously known sequence variations in SLC26A5: g.56471G>A; and, g.67439T>C (Table 2, Table 3). No subject was found to be homozygous for any coding region sequence variation in SLC26A5.
###end p 30
###begin title 31
###xml 41 49 41 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5.</italic>
Heterozygosity of sequence variations in SLC26A5.
###end title 31
###begin p 32
Heterozygosity is provided for each DNA sequence variation. n = the number of individuals studied. Novel variants are shown in bold type.
###end p 32
###begin title 33
Analysis of sequence variants in IVS2-2A>G heterozygotes
###end title 33
###begin p 34
###xml 162 169 162 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
###xml 169 173 169 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005762-Liu1">[15]</xref>
###xml 218 222 218 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005762-Tang1">[16]</xref>
###xml 315 323 315 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5.</italic>
###xml 433 440 433 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
###xml 457 464 457 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005762-t004">Table 4</xref>
###xml 18 26 <span type="species:ncbi:9606">patients</span>
Eight subjects (4 patients and 4 controls) included in this study were heterozygous for the previously reported g.24586A>G (IVS2-2A>G) nucleotide substitution in SLC26A5[15]. These 8 subjects were previously described [16] and were included here for further evaluation of the coding and near coding DNA sequence of SLC26A5. In addition to carrying the IVS2-2A>G variant, these subjects also carried additional sequence variations in SLC26A5 as described in Table 4.
###end p 34
###begin title 35
###xml 42 49 42 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
Other DNA sequence variations observed in SLC26A5 IVS2-2A>G heterozygotes.
###end title 35
###begin p 36
###xml 96 103 96 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
###xml 47 54 <span type="species:ncbi:9606">patient</span>
Additional sequence variations observed in the patient and control samples heterozygous for the SLC26A5 IVS2-2A>G variant are shown. All eight subjects were also homozygous for the variant alleles at g.56471G>A, g.67439T>C, and g.69036T>C (not shown). Het = heterozygous; Hom = homozygous; Ref = reference sequence allele; Var = variant allele.
###end p 36
###begin title 37
In silico analysis of amino acid sequence variations
###end title 37
###begin p 38
###xml 101 105 101 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005762-Applied1">[17]</xref>
###xml 118 122 118 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005762-Toth1">[18]</xref>
###xml 191 195 191 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005762-Ramensky1">[20]</xref>
###xml 208 212 208 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005762-Ng1">[21]</xref>
The p.I663V amino acid sequence variation observed in this study, and the previously reported p.I67V [17] and p.R150Q [18] amino acid sequence variations were evaluated using the PolyPhen () [20] and SIFT () [21] sequence analysis algorithms and by multiple sequence alignment of prestin orthologs using the HomoloGene application available through the National Center for Biotechnology Information (NCBI) web site ().
###end p 38
###begin p 39
###xml 363 370 363 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005762-t005">Table 5</xref>
###xml 504 511 504 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005762-t005">Table 5</xref>
###xml 317 322 <span type="species:ncbi:9606">human</span>
###xml 411 414 <span type="species:ncbi:9615">dog</span>
###xml 416 419 <span type="species:ncbi:9913">cow</span>
###xml 421 426 <span type="species:ncbi:10090">mouse</span>
###xml 431 434 <span type="species:ncbi:10116">rat</span>
PolyPhen analysis predicts the p.I67V and p.I663V variants would be benign and the p.R150Q variant may be possibly damaging. SIFT analysis predicts all three variants, p.I67V, p.R150Q, and p.I663V would be tolerated (data not shown). The degree of conservation of amino acids numbered p.I67, p.R150 and p.I663 in the human prestin amino acid sequence is shown in Table 5. All three amino acids are conserved in dog, cow, mouse and rat. Conservation of these amino acids in other species varies as shown (Table 5).
###end p 39
###begin title 40
###xml 65 69 65 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005762-Applied1">[17]</xref>
###xml 71 75 71 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005762-Toth1">[18]</xref>
Multiple sequence alignment for observed and previously reported [17], [18] amino acid sequence variations in prestin.
###end title 40
###begin p 41
###xml 80 90 80 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. sapiens</italic>
###xml 80 90 <span type="species:ncbi:9606">H. sapiens</span>
###xml 239 244 <span type="species:ncbi:9606">human</span>
Amino acid alignments of prestin orthologs from various species are shown using H. sapiens as the anchor sequence. Amino acid (aa) positions 67, 150, and 663 indicated in the top row of columns 3-5 refer to the amino acid positions in the human prestin amino acid sequence. Reference sequences used are derived from the NCBI protein database and aligned using the NCBI HomoloGene multiple sequence alignment tool ().
###end p 41
###begin title 42
Haplotype analysis of SLC26A5
###end title 42
###begin p 43
###xml 30 37 30 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
###xml 176 183 176 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
###xml 229 233 229 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005762-Barrett1">[22]</xref>
###xml 517 521 517 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005762-The1">[23]</xref>
###xml 122 129 <span type="species:ncbi:9606">patient</span>
###xml 288 295 <span type="species:ncbi:9606">patient</span>
###xml 338 345 <span type="species:ncbi:9606">patient</span>
###xml 395 402 <span type="species:ncbi:9606">patient</span>
To determine whether specific SLC26A5 alleles might be associated with hearing loss, and therefore overrepresented in the patient group, haplotypes and haplotype blocks within SLC26A5 were derived using HaploView 4.0 software () [22]. Haplotypes and haplotype blocks were derived for the patient group, the control group and the combined patient-control cohort. Haplotype blocks derived for the patient-control cohort were compared to haplotype blocks derived for the International HapMap Project database markers () [23].
###end p 43
###begin p 44
###xml 16 23 16 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
###xml 233 240 233 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
###xml 295 303 295 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005762-g001">Figure 1</xref>
###xml 46 54 <span type="species:ncbi:9606">patients</span>
The predominant SLC26A5 haplotype observed in patients was also the predominant haplotype observed among controls. Although some differences are observed in the boundaries of haplotype blocks, the overall haplotype block pattern for SLC26A5 appears similar for each of the four groups analyzed (Figure 1).
###end p 44
###begin title 45
###xml 22 30 <span type="species:ncbi:9606">patients</span>
Haplotype analysis of patients and controls compared to International HapMap Project database markers.
###end title 45
###begin p 46
###xml 252 259 252 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
###xml 503 510 503 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
###xml 763 767 763 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005762-Applied1">[17]</xref>
###xml 90 98 <span type="species:ncbi:9606">patients</span>
###xml 110 118 <span type="species:ncbi:9606">patients</span>
Haplotype blocks as determined by HaploView 4.0 are shown as shaded bars and compared for patients, controls, patients and controls combined (Combined), and the International HapMap Project database markers (HapMap). The location of markers within the SLC26A5 gene is shown at the top of the figure. DNA sequence variations are shown above the haplotype blocks. Note: The only marker observed in this study that is included in the International HapMap Project database is rs7779997 in IVS5. The genomic SLC26A5 nucleotides spanned by the haplotype blocks derived from the International HapMap Project database markers are shown at the bottom of the figure. Abbreviations and symbols used: IVS, intervening sequence (intron); *formerly hCG1811409, Celera database [17]; #, C allele noted is variant allele, not reference sequence allele; -, Variant allele not detected; +, Reference allele not detected; 1, 2, 3, 4, represent haplotype block designations derived from and assigned by HaploView 4.0 software analysis of the International HapMap Project database markers. The reference sequence (undeleted) allele of variant rs66928926 (g.69917_69919delTCT) is designated as "T" and of variant rs72655394 (g.70078_70082delATATA) is designated as "A." Novel variants are shown in bold type.
###end p 46
###begin title 47
Discussion
###end title 47
###begin p 48
###xml 50 57 50 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
###xml 170 177 170 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
###xml 210 217 210 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005762-t001">Table 1</xref>
###xml 219 226 219 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005762-t002">Table 2</xref>
###xml 228 235 228 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005762-t003">Table 3</xref>
###xml 423 431 <span type="species:ncbi:9606">patients</span>
###xml 626 634 <span type="species:ncbi:9606">patients</span>
Twenty-three different DNA sequence variations in SLC26A5, 14 of which are novel, were observed. Allelic variation for two previously reported DNA sequence variations in SLC26A5 was not observed in this study (Table 1, Table 2, Table 3). Twelve of the novel sequence variations observed are single nucleotide substitutions (SNPs) while 2 are small deletions. Four novel DNA sequence variations were found exclusively among patients. Seven novel DNA sequence variations were found exclusively among controls. Three novel DNA sequence variations, plus an additional 9 previously reported sequence variations, were found in both patients and controls.
###end p 48
###begin p 49
###xml 106 114 106 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5.</italic>
###xml 201 208 201 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
###xml 435 443 <span type="species:ncbi:9606">patients</span>
###xml 506 514 <span type="species:ncbi:9606">patients</span>
Twenty-one of the 23 DNA sequence variations identified in this study were found in non-coding regions of SLC26A5. Two DNA sequence variations, both of which are novel, were found in coding regions of SLC26A5. Both coding region changes, a nucleotide substitution predicted not to alter the amino acid sequence of prestin, p.S434S, and a nucleotide substitution predicted to result in a missense variation, p.I663V, were found only in patients. No statistically significant difference was observed between patients and controls in the frequency of any DNA sequence variation identified in this study.
###end p 49
###begin p 50
###xml 111 118 111 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
###xml 193 197 193 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005762-Liu1">[15]</xref>
###xml 223 227 223 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005762-Applied1">[17]</xref>
###xml 259 263 259 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005762-Toth1">[18]</xref>
###xml 105 110 <span type="species:ncbi:9606">human</span>
###xml 657 663 <span type="species:ncbi:9606">humans</span>
Prior to this report, only three other DNA sequence variations expected to affect the coding sequence of human SLC26A5 were known: splice site variant IVS2-2A>G upstream of the ATG start codon [15]; missense variant p.I67V [17]; and, missense variant p.R150Q [18]. Although additional coding sequence variants will reasonably be expected to be found in future studies it is striking that such a small number of coding sequence variants have been described so far in this rather large gene whose longest isoform produces a protein containing 744 amino acids. This observation suggests a remarkably high degree of conservation of this SLC26 family protein in humans.
###end p 50
###begin p 51
###xml 174 178 174 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005762-Liu1">[15]</xref>
###xml 248 255 248 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
###xml 548 552 548 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005762-Liu1">[15]</xref>
###xml 821 825 821 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005762-Tang1">[16]</xref>
###xml 966 970 966 970 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005762-Tang1">[16]</xref>
###xml 1172 1179 1172 1179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
###xml 1257 1261 1257 1261 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GJB2</italic>
###xml 1348 1352 1348 1352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005762-Green1">[24]</xref>
###xml 1402 1409 1402 1409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
###xml 1464 1468 1464 1468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005762-VanCamp1">[14]</xref>
###xml 1553 1560 1553 1560 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
###xml 1594 1598 1594 1598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005762-Tang1">[16]</xref>
###xml 97 105 <span type="species:ncbi:9606">patients</span>
###xml 407 415 <span type="species:ncbi:9606">patients</span>
###xml 634 641 <span type="species:ncbi:9606">patient</span>
###xml 1041 1047 <span type="species:ncbi:9606">humans</span>
###xml 1157 1163 <span type="species:ncbi:9606">humans</span>
###xml 1575 1580 <span type="species:ncbi:9606">human</span>
The IVS2-2A>G variant reported in 2003 by Liu et al. was found in that study in hearing impaired patients, including two probands homozygous for the variant, and in controls [15]. This sequence variation was suspected of disrupting the splicing of SLC26A5 exon 3, which contains the prestin ATG start codon, thereby disrupting prestin protein production. However, the difference in allele frequency between patients and controls in the study was not statistically significant if the consanguineous proband was excluded from the analysis, p = 0.056 [15]. In an effort to further analyze the IVS2-2A>G transition, we reported in 2005 a patient-control cohort that demonstrated a carrier frequency for the IVS2-2A>G transition among deaf Caucasians of 5.6% and a carrier frequency among control Caucasians of 4.1%, p = 0.66 [16]. In addition, we identified five possible alternate splice sites in intron 2 which could potentially compensate for the IVS2-2A>G variation [16]. If the IVS2-2A>G variant was in fact associated with hearing loss in humans, based on the carrier rate of 4.1% observed among Caucasians, the contribution to hereditary hearing loss in humans of this SLC26A5 variant could reasonably be expected to be greater than that of mutations in GJB2, encoding Connexin 26, which have a carrier rate among Caucasians of approximately 3% [24]. Based on these observations, it is curious that SLC26A5 has not been mapped by linkage studies as a DFN locus [14]. Further investigation is needed into what role, if any, the IVS2-2A>G variation in SLC26A5 might have in human hearing loss [16].
###end p 51
###begin p 52
###xml 71 75 71 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005762-Applied1">[17]</xref>
###xml 489 496 489 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005762-t005">Table 5</xref>
###xml 556 564 <span type="species:ncbi:9606">patients</span>
The p.I67V amino acid substitution was reported in the Celera database [17]. Because nothing is known about the health or hearing status of the individual(s) carrying this variant, its potential pathogenicity is unknown. The PolyPhen protein analysis tool predicts the p.I67V variation to be benign and the SIFT protein analysis tool predicts the p.I67V variation to be tolerated (data not shown). Multiple sequence alignment demonstrates a high degree of conservation of this amino acid (Table 5). In this study, the p.I67V variant was not observed among patients and was not sought among controls. Further investigation of the p.I67V amino acid variant is needed to assess what impact, if any, it might have on prestin production, trafficking and/or function.
###end p 52
###begin p 53
###xml 215 219 215 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005762-Toth1">[18]</xref>
###xml 476 483 476 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005762-t005">Table 5</xref>
###xml 91 98 <span type="species:ncbi:9606">patient</span>
###xml 544 552 <span type="species:ncbi:9606">patients</span>
The previously reported p.R150Q amino acid substitution was observed in a hearing impaired patient and his normal-hearing father, suggesting that this amino acid substitution is not sufficient to cause hearing loss [18]. PolyPhen analysis suggests the p.R150Q variant may be possibly damaging, however, SIFT analysis predicts this variation would be tolerated (data not shown). Multiple sequence alignment demonstrates a fairly high degree of conservation of this amino acid (Table 5). In this study, the p.R150Q variant was not observed among patients and was not sought among controls. Further analysis of the p.R150Q amino acid variant is needed to assess what role, if any, it might have in hearing loss.
###end p 53
###begin p 54
###xml 282 286 282 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GJB2</italic>
###xml 286 290 286 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005762-Tang2">[25]</xref>
###xml 406 410 406 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GJB2</italic>
###xml 647 654 647 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
###xml 136 143 <span type="species:ncbi:9606">patient</span>
###xml 297 304 <span type="species:ncbi:9606">patient</span>
The novel DNA sequence variation g.56167A>G which is predicted to represent a synonymous p.S434S variation was found in this study in a patient with bilateral, progressive, mild to moderate sensorineural hearing loss who is also homozygous for the controversial p.V37I variation in GJB2[25]. This patient also demonstrates mildly prominent vestibular aqueducts bilaterally, a finding not consistent with a GJB2-based etiology and suggestive of a more complex etiology for the hearing loss. Because this sequence variation does not result in an amino acid substitution, it would not be predicted to be pathogenic unless it disrupts splicing of the SLC26A5 transcript. Since the p.S434S variation does not predict an amino acid substitution, analysis by PolyPhen and SIFT is not warranted. Further analysis of the g.56167A>G DNA sequence variant is required to assess what impact, if any, it might have on prestin production, trafficking and/or function.
###end p 54
###begin p 55
###xml 266 270 266 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GJB2</italic>
###xml 323 327 323 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GJB2</italic>
###xml 832 839 832 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005762-t005">Table 5</xref>
###xml 143 150 <span type="species:ncbi:9606">patient</span>
###xml 336 343 <span type="species:ncbi:9606">patient</span>
###xml 379 386 <span type="species:ncbi:9606">patient</span>
The novel DNA sequence variation g. 69743A>G which is predicted to result in a p.I663V amino acid substitution was observed in this study in a patient with bilateral, profound sensorineural hearing loss who is also homozygous for the pathogenic c.35delG mutation in GJB2. The detection of a homozygous c.35delG mutation in GJB2 in this patient provides a clear etiology for this patient's hearing loss without the need to invoke additional contributing factors. Further, PolyPhen analysis predicts the p.I663V variant would be benign and SIFT analysis predicts p.I663V would be tolerated by the prestin protein (data not shown). Multiple sequence alignment demonstrates some degree of conservation of this amino acid, especially among mammals, however, in some other species the isoleucine at this position is replaced by a valine (Table 5). Further analysis of the p.I663V amino acid variant is needed to assess what impact, if any, this variant might have on prestin production, trafficking and/or function.
###end p 55
###begin p 56
###xml 22 29 22 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
###xml 196 203 196 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
###xml 279 283 279 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005762-Barrett1">[22]</xref>
###xml 462 466 462 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005762-The1">[23]</xref>
###xml 1178 1182 1178 1182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005762-The1">[23]</xref>
###xml 129 136 <span type="species:ncbi:9606">patient</span>
###xml 307 315 <span type="species:ncbi:9606">patients</span>
###xml 373 380 <span type="species:ncbi:9606">patient</span>
###xml 563 570 <span type="species:ncbi:9606">patient</span>
###xml 590 597 <span type="species:ncbi:9606">patient</span>
###xml 839 847 <span type="species:ncbi:9606">patients</span>
###xml 1009 1016 <span type="species:ncbi:9606">patient</span>
Haplotype analysis of SLC26A5 was conducted to determine whether novel or unusual haplotypes or haplotype blocks occurred in the patient population that might suggest an association of particular SLC26A5 alleles with hearing loss. Haplotype analysis using HaploView 4.0 software [22] revealed haplotypes in patients similar to those in controls and haplotype blocks in the patient-control cohort similar to those generated from International HapMap Project data [23]. Although slight differences in the boundaries of the haplotype blocks are observed between the patient, control, combined patient-control cohort, and International HapMap Project database marker groups, the overall haplotype block pattern is similar between the four groups. As such, these data fail to detect any major haplotypes or haplotype block structures unique to patients. It is likely that the slight differences in haplotype blocks observed are related to the small population size utilized in this study. Evaluation of additional patient and control populations in future studies may reveal haplotype blocks more similar to those derived using markers from the International HapMap Project database [23].
###end p 56
###begin p 57
###xml 80 87 80 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
###xml 286 293 286 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
###xml 319 324 319 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GJB2-</italic>
###xml 640 647 640 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
###xml 74 79 <span type="species:ncbi:9606">human</span>
###xml 211 219 <span type="species:ncbi:9606">patients</span>
###xml 382 390 <span type="species:ncbi:9606">patients</span>
###xml 466 473 <span type="species:ncbi:9606">patient</span>
###xml 695 700 <span type="species:ncbi:9606">human</span>
In summary, 12 novel SNPs and 2 novel small deletions are reported in the human SLC26A5 gene encoding prestin. Although no significant difference in the frequency of any DNA sequence variation was found between patients and controls and no data was found to support the hypothesis that SLC26A5 may act as a modifier of GJB2-based hearing loss in this population of hearing impaired patients, the population included in this study was small. Future studies on larger patient and control populations may yield more informative results. Identification of the 14 novel DNA sequence variations described here should facilitate future studies of SLC26A5 and the role of the encoded prestin protein in human hearing sensitivity and hearing loss.
###end p 57
###begin title 58
Materials and Methods
###end title 58
###begin title 59
Ethics Statement
###end title 59
###begin p 60
This work was approved by the Baylor College of Medicine Institutional Review Board (IRB). Written informed consent was obtained from all subjects, as directed by the IRB.
###end p 60
###begin title 61
Subjects
###end title 61
###begin p 62
###xml 75 79 75 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005762-Tang1">[16]</xref>
###xml 81 85 81 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005762-Tang2">[25]</xref>
###xml 166 170 166 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GJB2</italic>
###xml 246 250 246 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005762-Tang2">[25]</xref>
###xml 284 291 284 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
###xml 310 314 310 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005762-Tang1">[16]</xref>
###xml 403 410 403 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
###xml 533 537 533 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GJB2</italic>
###xml 607 614 607 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
###xml 647 652 647 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GJB2-</italic>
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
###xml 97 105 <span type="species:ncbi:9606">patients</span>
###xml 446 454 <span type="species:ncbi:9606">patients</span>
###xml 483 491 <span type="species:ncbi:9606">patients</span>
Patients and controls were identified as previously described and reported [16], [25]. Of the 28 patients included in this study: 22 carry DNA sequence variations in GJB2, encoding Connexin 26, of known, controversial, or uncertain pathogenicity [25]; 4 carry the previously reported SLC26A5 IVS2-2A>G variant [16]; and, 2 were suspected of carrying another non-coding sequence variation in intron 2 of SLC26A5 (data not shown). The ethnicity of patients is not always known. The 22 patients carrying known or potential mutations in GJB2 were included in this study specifically to test the hypothesis that SLC26A5 might act as a modifier gene of GJB2-based hearing loss.
###end p 62
###begin p 63
###xml 243 250 243 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
###xml 269 273 269 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005762-Tang1">[16]</xref>
###xml 340 347 340 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
Controls were obtained from the Baylor Polymorphism Resource (). The control population includes 4 different ethnic groups. Ethnicity of individuals in the control population was self-identified. Four controls previously reported to carry the SLC26A5 IVS2-2A>G variant [16] were included in this study specifically to search for additional SLC26A5 variants in these individuals.
###end p 63
###begin title 64
Reference sequences
###end title 64
###begin p 65
###xml 90 97 90 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
###xml 127 134 127 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
Entrez nucleotide database () sequence NT_079596.2 was used as the reference sequence for SLC26A5. Numbering of nucleotides in SLC26A5 begins with position 1 of the Entrez sequence as position g.1.
###end p 65
###begin p 66
Entrez protein database () sequence NP_945350.1 was used as the reference sequence for prestin. Numbering of amino acids in prestin begins with position 1 of the Entrez sequence as position p.1.
###end p 66
###begin title 67
DNA sequence variation nomenclature
###end title 67
###begin p 68
###xml 97 101 97 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005762-denDunnen1">[26]</xref>
###xml 103 107 103 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005762-Ogino1">[27]</xref>
DNA and protein sequence variations are named according to standard nomenclature recommendations [26], [27].
###end p 68
###begin title 69
Specimen collection
###end title 69
###begin p 70
###xml 24 28 24 28 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005762-Tang1">[16]</xref>
###xml 30 34 30 34 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005762-Tang2">[25]</xref>
###xml 113 121 <span type="species:ncbi:39329">lavender</span>
###xml 173 181 <span type="species:ncbi:9606">patients</span>
As previously described [16], [25], blood samples were collected from all subjects by peripheral venipuncture in lavender top (EDTA) and/or yellow top (ACD) tubes. For some patients and all control specimens, lymphoblastoid cell lines were established from blood samples collected in yellow top (ACD) tubes by standard Epstein Barr virus mediated transformation.
###end p 70
###begin title 71
DNA isolation
###end title 71
###begin p 72
###xml 24 28 24 28 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005762-Tang1">[16]</xref>
###xml 30 34 30 34 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005762-Tang2">[25]</xref>
###xml 93 101 <span type="species:ncbi:39329">lavender</span>
As previously described [16], [25], genomic DNA was isolated from blood samples collected in lavender top (EDTA) tubes using the PUREGENE(R) DNA Purification Kit for whole blood and bone marrow and from cultured cells using the PUREGENE(R) DNA Purification Kit for cells, tissue, body fluids, and Gram-negative bacteria (Gentra Systems, Inc., Minneapolis, Minnesota, USA) according to the manufacturer's specifications.
###end p 72
###begin title 73
DNA sequence analysis
###end title 73
###begin title 74
###xml 3 11 <span type="species:ncbi:9606">patients</span>
Of patients
###end title 74
###begin p 75
###xml 67 74 67 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
###xml 159 181 159 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCR and DNA sequencing</italic>
###xml 265 269 265 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005762-Tang1">[16]</xref>
###xml 471 484 469 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RFLP analysis</italic>
###xml 489 507 487 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TaqMan&#174; analysis</italic>
###xml 640 647 636 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
###xml 97 104 <span type="species:ncbi:9606">patient</span>
###xml 309 317 <span type="species:ncbi:9606">patients</span>
The coding and near coding regions of all exons in all isoforms of SLC26A5 were sequenced in the patient population as described below in the section entitled PCR and DNA sequencing except that analysis of the IVS2-2A>G variant was conducted as reported previously [16]. Novel sequence variants identified in patients in this study were confirmed either by sequencing in the opposite direction or by RFLP or TaqMan(R) analysis as described below in the sections entitled RFLP analysis and TaqMan(R) analysis, except that the g.55275A>G variant was also confirmed by bidirectional sequencing. Due to the size of the study population and the SLC26A5 gene, at least one occurrence of every previously reported variant assayed by sequencing was confirmed by a second sequencing reaction in the opposite direction or by TaqMan(R) analysis, however, additional occurrences were only confirmed when deemed appropriate for control purposes or necessary based on the appearance of the initial sequence electropherogram.
###end p 75
###begin title 76
Of controls
###end title 76
###begin p 77
###xml 154 176 154 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCR and DNA sequencing</italic>
###xml 269 282 267 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RFLP analysis</italic>
###xml 287 305 285 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TaqMan&#174; analysis</italic>
###xml 576 583 572 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
###xml 74 82 <span type="species:ncbi:9606">patients</span>
Screening of the control population for the sequence variants observed in patients was conducted by sequencing as described below in the section entitled PCR and DNA sequencing or, as indicated, by RFLP or TaqMan(R) analysis as described below in the sections entitled RFLP analysis and TaqMan(R) analysis. Novel sequence variants identified only in controls in this study were confirmed either by sequencing in the opposite direction or by a second confirmatory sequencing reaction in the same direction as the first. However, due to the size of the study population and the SLC26A5 gene, previously reported variants assayed by sequencing were only confirmed by a second sequencing reaction either in the opposite direction or in the same direction as the first when deemed necessary for confirmation based on the appearance of the initial sequence electropherogram.
###end p 77
###begin title 78
PCR and DNA sequencing
###end title 78
###begin p 79
###xml 107 115 107 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5,</italic>
To minimize the number of PCR reactions required to amplify the coding and near coding genomic sequence of SLC26A5, a combination of standard and long PCR was used. Standard PCR was conducted with Taq polymerase (GE Healthcare, Piscataway, NJ, USA). Long PCR was conducted with the Expand Long Template PCR System (Roche Applied Science, Indianapolis, IN, USA). PCR reactions were conducted as follows: initial denaturation at 94degreesC was followed by 40 cycles of amplification which included denaturation at 94degreesC, annealing at temperatures ranging from 53degreesC to 60degreesC dependent upon primer sequence, and extension at 70degreesC for standard PCR and 68degreesC for long PCR. Amplification was followed by a final extension at 70degreesC for standard PCR and 68degreesC for long PCR.
###end p 79
###begin p 80
###xml 288 292 288 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005762-Tang1">[16]</xref>
Amplified fragments were sequenced using either PCR or inset sequencing primers with fluorescently labeled dideoxynucleotides by chain terminator (Sanger) methods using the ABI BigDye Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems, Foster City, CA, USA) as previously described [16]. Sequencing reactions were analyzed on an ABI Prism 3130 Genetic Analyzer according to manufacturer's specifications (Applied Biosystems, Foster City, CA, USA).
###end p 80
###begin p 81
Primer sequences and detailed PCR conditions will be provided upon request.
###end p 81
###begin title 82
RFLP analysis
###end title 82
###begin p 83
Restriction digests were performed according to the restriction enzyme manufacturer's specifications. PCR fragments containing position g.33190 were digested with restriction enzyme BstNI (New England Biolabs, Ipswich, MA, USA). When the consensus sequence was present, the 350 bp PCR fragment was not digested. When the T>G variant sequence was present, the digestion resulted in two fragments of 250 bp and 100 bp.
###end p 83
###begin p 84
PCR fragments containing position g.53884 were digested with restriction enzyme EcoO109I (New England Biolabs, Ipswich, MA, USA). When the consensus sequence was present, the digestion resulted in two fragments of 420 bp and 180 bp. When the C>T variant sequence was present, the 600 bp PCR fragment was not digested.
###end p 84
###begin p 85
PCR fragments containing position g.66012 were digested with restriction enzyme DraIII (New England Biolabs, Ipswich, MA, USA). When the consensus sequence was present, the digestion resulted in two fragments of 225 bp and 140 bp. When the C>T variant sequence was present, the 365 bp PCR fragment was not digested.
###end p 85
###begin title 86
TaqMan(R) analysis
###end title 86
###begin p 87
TaqMan(R) assays were performed according to the manufacturer's recommendations. Premade TaqMan(R) SNP Genotyping Assays (Applied Biosystems, Foster City, CA, USA) were used for the detection of sequence variants g.33167T>C (Assay ID C_25989012_10), g.34821C>T (Assay ID C_25742018_10) and g.69036T>C (Assay ID C_25986987_10). Custom TaqMan(R) SNP Genotyping Assays were designed for analysis of sequence variants g.55275A>G and g.67439T>C.
###end p 87
###begin title 88
In silico DNA analysis
###end title 88
###begin p 89
###xml 104 108 104 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005762-Ramensky1">[20]</xref>
###xml 121 125 121 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005762-Ng1">[21]</xref>
Missense amino acid sequence variations were analyzed for potential pathogenicity using the PolyPhen () [20] and SIFT () [21] sequence analysis algorithms. Both algorithms use information from multiple sequence alignments of similar proteins to predict whether an amino acid substitution at any given position would be tolerated. PolyPhen also incorporates analysis of structural information into predictions. Protein sequence P58743 (version P58743.1, GI:20139418) from the UniProtKB/Swiss-Prot () and NCBI GenPept databases () was used as the reference sequence for these analyses.
###end p 89
###begin p 90
###xml 289 296 289 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005762-t005">Table 5</xref>
Multiple sequence alignments for prestin orthologs from multiple species were derived using the HomoloGene application on the National Center for Biotechnology Information (NCBI) web site (). Species and protein reference sequences included in the multiple sequence alignment are shown in Table 5.
###end p 90
###begin title 91
dbSNP submission
###end title 91
###begin p 92
###xml 46 53 46 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
###xml 148 155 148 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005762-t001">Table 1</xref>
All novel DNA sequence variants identified in SLC26A5 in this study were submitted to dbSNP () and assigned rs numbers in Build 130 as indicated in Table 1.
###end p 92
###begin title 93
Statistical analysis
###end title 93
###begin p 94
###xml 11 12 11 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 58 66 <span type="species:ncbi:9606">patients</span>
Two-tailed P values associated with allele frequencies in patients and controls were calculated using the Fisher's exact test analysis of 2x2 contingency tables algorithm available through GraphPad QuickCalcs Online Calculator for Scientists ().
###end p 94
###begin title 95
Heterozygosity
###end title 95
###begin p 96
###xml 15 18 15 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(H)</italic>
Heterozygosity (H) is calculated as the number of heterozygous individuals divided by the total number of individuals tested.
###end p 96
###begin title 97
Haplotype analysis
###end title 97
###begin p 98
###xml 65 69 65 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005762-Barrett1">[22]</xref>
###xml 116 120 116 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005762-The1">[23]</xref>
###xml 162 169 162 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC26A5</italic>
Haplotype analysis was conducted using HaploView 4.0 software () [22]. International HapMap Project data markers () [23] and DNA sequence variations evaluated in SLC26A5 in this study were uploaded into HaploView 4.0 software for analysis as singletons in Linkage format. Blocks were defined using the four gamete rule. Haplotypes above 1% were examined.
###end p 98
###begin p 99
The authors thank the individuals and families who agreed to participate in this research. The authors also thank the Baylor Polymorphism Resource for the availability of the control specimens used in this work, John Belmont MD, PhD for guidance on use of the HaploView 4.0 algorithm, and Aletta Moore for editorial assistance with the manuscript.
###end p 99
###begin title 100
References
###end title 100
###begin article-title 101
Sensory Transduction.
###end article-title 101
###begin article-title 102
The active cochlea.
###end article-title 102
###begin article-title 103
Prestin, a new type of motor protein.
###end article-title 103
###begin article-title 104
Prestin is the motor protein of cochlear outer hair cells.
###end article-title 104
###begin article-title 105
Prestin and the cochlear amplifier.
###end article-title 105
###begin article-title 106
Nonmammalian orthologs of prestin (SLC26A5) are electrogenic divalent/chloride anion exchangers.
###end article-title 106
###begin article-title 107
The SLC26 gene family of multifunctional anion exchangers.
###end article-title 107
###begin article-title 108
###xml 43 48 <span type="species:ncbi:10090">mouse</span>
Genomic characterization and expression of mouse prestin, the motor protein of outer hair cells.
###end article-title 108
###begin article-title 109
Prestin is required for electromotility of the outer hair cell and for the cochlear amplifier.
###end article-title 109
###begin article-title 110
Effects of cyclic nucleotides on the function of prestin.
###end article-title 110
###begin article-title 111
N-terminal-mediated homomultimerization of prestin, the outer hair cell motor protein.
###end article-title 111
###begin article-title 112
Intracellular anions as the voltage sensor of prestin, the outer hair cell motor protein.
###end article-title 112
###begin article-title 113
Essential helix interactions in the anion transporter domain of prestin revealed by evolutionary trace analysis.
###end article-title 113
###begin article-title 114
Hereditary Hearing Loss Homepage.
###end article-title 114
###begin article-title 115
Prestin, a cochlear motor protein, is defective in non-syndromic hearing loss.
###end article-title 115
###begin article-title 116
High frequency of the IVS2-2A>G DNA sequence variation in SLC26A5, encoding the cochlear motor protein prestin, precludes its involvement in hereditary hearing loss.
###end article-title 116
###begin article-title 117
TaqMan SNP Genotyping Assays.
###end article-title 117
###begin article-title 118
###xml 22 27 <span type="species:ncbi:9606">human</span>
A new mutation in the human pres gene and its effect on prestin function.
###end article-title 118
###begin article-title 119
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human non-synonymous SNPs: server and survey.
###end article-title 119
###begin article-title 120
###xml 15 20 <span type="species:ncbi:9606">human</span>
Accounting for human polymorphisms predicted to affect protein function.
###end article-title 120
###begin article-title 121
Haploview: analysis and visualization of LD and haplotype maps.
###end article-title 121
###begin article-title 122
The International HapMap Project.
###end article-title 122
###begin article-title 123
Carrier rates in the midwestern United States for GJB2 mutations causing inherited deafness.
###end article-title 123
###begin article-title 124
DNA sequence analysis of GJB2, encoding connexin 26: observations from a population of hearing impaired cases and variable carrier rates, complex genotypes, and ethnic stratification of alleles among controls.
###end article-title 124
###begin article-title 125
###xml 36 41 <span type="species:ncbi:9606">human</span>
Nomenclature for the description of human sequence variations.
###end article-title 125
###begin article-title 126
Standard mutation nomenclature in molecular diagnostics: practical and educational challenges.
###end article-title 126
###begin p 127
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 127
###begin p 128
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by the Alkek Foundation and the Allbritton-Alford fund (JSM, HYT, RLA) and NIDCD DC00354, DC008134-01 (FAP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 128

